Skip to content
Sunday, October 11, 2026
AreonBet UK offers expert reviews and insights on online be…

Users Discontinuing Slimming Jabs Gain Back Weight at a Quadrupled Rate Than Dieters

Illustration of medical syringe and scale
Weight management involves long-term strategies.

A recent study indicates that individuals who stop using popular weight-loss injections like Wegovy and Mounjaro tend to recover shed pounds at a significantly accelerated pace than those who halt conventional lifestyle programs.

Research printed in a major health publication points out that while overweight people frequently drop a large proportion of their body weight while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month upon discontinuation.

"People using such treatments should be informed of the potential of quick rebound weight gain when the treatment ends," cautioned researcher Dr. Susan Jebb.

This pace of recovery means a return to pre-treatment mass within about a year and a half.

Analyzing Approaches

The analysis, which reviewed dozens of trials involving thousands of participants, contrasted the outcomes of these new drugs with older methods.

The team point out that people who lose weight through lifestyle changes alone generally see a less rapid weight regain—perhaps 100 grams monthly—after stopping.

Understanding the Quick Regain

Nutrition scientists suggest the mode of action of the jabs explains the accelerated weight return.

These medications mimic a body's own chemical called glucagon-like peptide-1, which controls appetite.

"Long-term administration of GLP-1 levels several times higher than the body's typical production might result in the system to generate a reduced amount of its own natural GLP-1, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this GLP-1 'fix' results in appetite is unsuppressed, making overeating far more likely."

A Chronic Issue?

Health authorities suggest the injections for people with weight-linked health risks, alongside prescribed diet and exercise modifications.

Many experts contend that, considering the likelihood of relapse, the treatment should be considered ongoing.

This perspective is supported by pharmaceutical companies, who state that the findings "highlight the long-term nature of excess weight," akin to managing diseases like high blood pressure.

User Testimonies

Individuals who have stopped the medication report a powerful return of hunger.

"It was like something that goes on and you're instantly starving," recalled an individual.

The struggle is worsened if individuals have not established permanent lifestyle or habit modifications during treatment.

Growing Use

Survey data show that a significant number of people in the UK have used these injections in the past year, with desire remaining high.

  • Use is higher among females compared to men.
  • The 40s and 50s age group shows the highest level of interest.
  • A large proportion access the drugs through private prescriptions rather than public health services.

In conclusion, clinicians caution that while these medications are potent tools for shedding pounds, they are not a magic cure and maintained weight loss relies on integrated behavioural changes.

AP
Written by

Aaron Perkins

A seasoned gambling analyst with over a decade of experience reviewing online casinos and betting sites across Europe.

AreonBet UK

Type to search articles.